Trecarichi, Enrico Maria
 Distribuzione geografica
Continente #
EU - Europa 4.657
NA - Nord America 2.824
AS - Asia 1.856
SA - Sud America 205
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 9.579
Nazione #
US - Stati Uniti d'America 2.782
DE - Germania 2.555
CN - Cina 1.085
SE - Svezia 537
SG - Singapore 426
IT - Italia 306
UA - Ucraina 292
FR - Francia 245
GB - Regno Unito 243
BR - Brasile 182
IE - Irlanda 134
FI - Finlandia 87
TR - Turchia 84
ID - Indonesia 80
IN - India 73
RU - Federazione Russa 69
PL - Polonia 64
CA - Canada 27
BE - Belgio 25
NL - Olanda 20
HK - Hong Kong 14
RO - Romania 12
VN - Vietnam 12
AR - Argentina 10
MX - Messico 10
IR - Iran 9
IL - Israele 8
JP - Giappone 8
KR - Corea 8
AT - Austria 7
BD - Bangladesh 7
CH - Svizzera 7
ES - Italia 7
AU - Australia 6
CI - Costa d'Avorio 6
EU - Europa 6
IQ - Iraq 6
CO - Colombia 5
HU - Ungheria 5
PK - Pakistan 5
VA - Santa Sede (Città del Vaticano) 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
KZ - Kazakistan 4
LV - Lettonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
ET - Etiopia 3
HR - Croazia 3
LT - Lituania 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BZ - Belize 2
CM - Camerun 2
CY - Cipro 2
DJ - Gibuti 2
DK - Danimarca 2
EC - Ecuador 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
ME - Montenegro 2
MU - Mauritius 2
MY - Malesia 2
TH - Thailandia 2
VE - Venezuela 2
ZA - Sudafrica 2
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
JM - Giamaica 1
KG - Kirghizistan 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
Totale 9.579
Città #
Chandler 552
Hangzhou 440
Singapore 264
Jacksonville 205
Nürnberg 202
Ashburn 156
San Mateo 153
Ann Arbor 144
Nanjing 136
Dublin 133
Dearborn 118
Beijing 109
Wilmington 81
Jakarta 80
Izmir 74
New York 74
Woodbridge 63
Lawrence 56
Munich 56
Kraków 55
Marseille 55
Milan 54
Boston 53
Moscow 52
Nanchang 52
Cattolica 45
Houston 45
Los Angeles 45
Redwood City 44
Bremen 37
Seattle 37
Kunming 31
Chicago 28
Shenyang 27
Frankfurt am Main 26
Brussels 25
Tianjin 23
Mountain View 22
Hebei 21
Princeton 21
Helsinki 20
Norwalk 20
Rome 20
São Paulo 19
Changsha 18
The Dalles 18
Guangzhou 17
Leawood 17
Redmond 17
Shanghai 17
Boardman 16
Lancaster 16
Hefei 15
University Park 15
Fairfield 14
Jinan 14
Fremont 13
Hong Kong 13
Zhengzhou 13
Costa Mesa 12
Augusta 11
Jiaxing 11
Toronto 11
London 10
Auburn Hills 9
Brooklyn 8
Düsseldorf 8
Ningbo 8
Nuremberg 8
Pune 8
San Jose 8
Seoul 8
Belo Horizonte 7
Hanoi 7
Paris 7
Renton 7
Abidjan 6
Andover 6
Buffalo 6
Cambridge 6
Edinburgh 6
Falls Church 6
Lanzhou 6
Mexico City 6
Monza 6
Ottawa 6
Santa Clara 6
Timisoara 6
Verona 6
Chongqing 5
Hyderabad 5
Lauterbourg 5
Portsmouth 5
Stockholm 5
Amsterdam 4
Budapest 4
Contursi Terme 4
Delhi 4
Erbil 4
Mcallen 4
Totale 4.481
Nome #
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 316
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 315
Factors associated with mortality in bacteremic patients with hematologic malignancies. 314
Factors associated with mortality in bacteremic patients with haematologic malignancies 310
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 279
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 254
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 252
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 223
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 189
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 188
Factors associated with mortality in bacteremic patients with hematologic malignancies. 179
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 177
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 172
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 168
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 163
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 162
Safety and effectiveness of transvenous lead extraction in octogenarians 156
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 151
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 151
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 149
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 146
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 146
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 142
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 140
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 135
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 134
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 132
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 127
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 126
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 126
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 118
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 116
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 115
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 115
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 112
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 109
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 105
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 104
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 104
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 104
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 103
Uncommon yeast infections in hematological patients: from diagnosis to treatment 99
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 98
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 98
Mortality in patients with early- or late-onset candidaemia 97
Mortality in patients, with early-or late-onset candidaemia 95
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 95
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 92
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 92
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 90
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 90
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 88
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 87
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 86
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 85
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 84
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 84
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 84
Epidemiological and clinical features of pyogenic spondylodiscitis. 83
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 83
Mortality in patients with early- or late-onset candidaemia 81
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 78
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 77
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 71
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 68
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 66
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia 66
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 66
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 62
Isavuconazole-Animal Data and Clinical Data 62
Mortality in patients with early- or late-onset candidaemia 56
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 56
When Viruses Meet Fungi: Tackling the Enemies in Hematology 52
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 50
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 50
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 45
Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey 33
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 32
Bloodstream infections caused by extended-spectrum-β-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy 31
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study 18
Utility, acceptability and applicability of a nucleic acid amplification test in comparison with a syndromic approach in the management of sexually transmitted diseases at Mulago National Referral Hospital in Uganda (ASTRHA): Protocol for an open-label, randomised controlled trial 8
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 5
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 5
New advances in management and treatment of cardiac implantable electronic devices infections 4
Totale 9.679
Categoria #
all - tutte 33.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020118 0 0 0 0 0 0 0 0 0 0 0 118
2020/2021715 75 77 20 66 80 52 64 29 107 15 117 13
2021/2022856 83 83 47 48 52 39 12 140 38 63 116 135
2022/20231.567 191 223 115 246 89 196 86 126 176 29 69 21
2023/2024649 39 198 13 26 19 91 48 23 9 25 81 77
2024/20251.152 50 35 109 30 171 51 41 56 213 99 280 17
Totale 9.679